Shares of Merck & Co. (MRK) rose 5% on Friday after the pharmaceutical giant reported positive developments across multiple oncology programs, reinforcing investor confidence in its efforts to extend the dominance of blockbuster cancer drug Keytruda ahead of looming patent expirations later this decade.The rally followed encouraging Phase 3 clinical…
Dell Technologies (DELL) ripped higher on Friday as a series of analyst upgrades and price target hikes fuelled intense…
Shares of Take-Two Interactive Software (TTWO) fell on Friday despite the video game publisher reporting better-than-expected quarterly results and…
Shares of Generac Holdings (GNRC) surged on Friday after Jefferies upgraded the backup power equipment maker, citing growing momentum…
Wall Street closed higher on Friday, with the Dow Jones Industrial Average reaching an intraday record high, as easing…
As the global financial community eagerly awaits SpaceX’s historic initial public offering (IPO) – rumoured to command some $1.7…
JPMorgan Chase is looking at ways to transfer risk tied to a portfolio of loans extended to private equity…
A rally in European technology stocks has continued largely unnoticed as broader equity markets across the region struggle under…
The FTSE 100 Index did relatively well this week, rising for four consecutive days and reaching its highest point…